Share This Page

Alzheimer's And Dementia Weekly

Support & Insight for the Autumn of Life

News

FDA Endorses Donanemab, Revolutionary Alzheimer’s Treatment

June 11, 2024 No Comments

The unanimous 11-0 FDA vote clears an exciting path for this new Alzheimer’s drug.

LEQEMBI® for Alzheimer’s Now in USA, China, Japan, South Korea

June 4, 2024 1 Comment

South Korea joined other countries in approving LEQEMBI® (generic lecanemab) for mild cognitive impairment, mild and early Alzheimer’s. Learn how Leqembi is treating Alzheimer’s around the world.

Bigger is Better: Brain Size Up 7%, Dementia Down 25%

May 28, 2024 1 Comment

In a span of 40 years, why did average brain size increase and dementia rates drop? A new UC-Davis study explores environmental factors behind this silent revolution.

Seroquel-quetiapine Prescriptions Drop 15% After Dementia Warning

May 22, 2024 3 Comments

“People with dementia living in nursing homes and in the community were prescribed less and we did not detect negative health impacts for these groups.”

Leqembi Injection, an Easier Alzheimer’s Treatment, Awaits FDA Approval

May 16, 2024 No Comments

LEQEMBI® is the newest Alzheimer’s drug. It is administered in hospitals via IV. Biogen applied to the FDA for approval of a home version using an “Autoinjector”. See how it works and learn its advantages.

Carolyn Davis Talks About Her Leqembi Infusions

May 7, 2024 No Comments

The newest and most promising drug to fight Alzheimer’s is Leqembi. Carolyn Davis is giving it a try. Learn about the promise, the risks and how it has restored her hope,

Brain Health Academy teacher from UsAgainstAlzheimer's

Brain Health Academy Launched by UsAgainstAlzheimer’s

May 5, 2024 1 Comment

Scheduled to begin on May 9, 2024, six new monthly sessions are now available in this free Continuing Education Program.

Wire Fraud Victim with Alzheimer’s Wins Citibank Lawsuit

April 26, 2024 No Comments

People with dementia may be even more vulnerable to fraud and scams than previously thought, according to an NIA study. See the story of one victim with a happy ending. Read the research.

AI vs. Daffodils: Crafting a Cheaper Alzheimer’s Drug

April 19, 2024 No Comments

Galantamine treats Alzheimer’s. Artificial intelligence and biosensors may pave the way to make this drug faster and cheaper.

Measuring a brain to see if it got bigger

Today’s Brains are 6% Larger with 20% Less Dementia

April 7, 2024 No Comments

A long, long time ago (1930), brains were smaller. Are today’s bigger brains connected to improvements in rates of dementia?

Adults and children walking on a leafy trail amidst vibrant autumn colors.

3 E’s Defend Against Dementia

September 22, 2025

Simple, low-cost lifestyle changes can significantly slow or prevent cognitive decline. New research offers hope for families, caregivers, and anyone invested in brain health.

anti-inflammatory, curcuma longa, curcumin

UCLA: Memory-Mood Boosted by Curcumin Despite Aging

September 19, 2025

The spice turmeric contains curcumin. In a UCLA study, curcumin significantly improved memory and mildly improved mood in people with memory problems.

Who Was Alzheimer’s Patient #1 ?

September 18, 2025

“She said, ‘I have lost myself.’ How did Doctor Alzheimer discover the heartbreaking disease of memory loss that bears his name?

Most Popular Stories

ai generated, doctor, neurologist, laboratory, hospital, research, medical research center, brain, brain research, neurons neurons, skull, brain cells, research, research, research, research, research, brain, brain

How Do You Know If Someone Has Alzheimer’s?

What are the early symptoms of Alzheimer’s? When to get a professional evaluation.

kid, coffee, cup, breakfast, tiny, kids, small, coffee, coffee, coffee, coffee, coffee, kids

Big Cup, Little Man: Picking Up the Earliest Signs of Alzheimer’s

SHORT-TERM MEMORY lapses are obvious signs of Alzheimer’s, but other tell-tale signals begin to show much earlier. Learn how to look for semantic impairments, such as simple questions about size.

85 with Dementia? Good Chance It’s HS-AGING, Not Alzheimer’s

Three important dementia studies focus on HS-AGING, a type of dementia almost as common as Alzheimer’s in the 85+ group. Yet few people have heard of it. Why? What makes it different?

Grandmother in black and white striped shirt hugging girl in black and white striped shirt

A Grandchild for One Day Keeps Dementia Away

An intriguing study of 120 grandmothers might surprise you. Doctors know socially engaged people have better cognition and less dementia. But can a person get too much of a good thing? What’s the right balance?